Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Muscle-Invasive Bladder Cancer (NMIBC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT03839472
What this trial is testing

Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)Bladder Tumor (TURBT)
Case Comprehensive Cancer Center
Large-scale testing (Phase 3)Not Yet RecruitingNCT07464145
What this trial is testing

NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerBladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Urothelial Carcinoma Bladder+2 more
Relmada Therapeutics, Inc. 393
Early research (Phase 1)Study completedNCT05375903
What this trial is testing

Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non-muscle Invasive Bladder CancerNMIBCCarcinoma in Situ of Bladder+3 more
UroGen Pharma Ltd. 51
Large-scale testing (Phase 3)WithdrawnNCT01284205
What this trial is testing

First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC

Who this might be right for
Bladder Cancer
Bioniche Life Sciences Inc.
Testing effectiveness (Phase 2)UnknownNCT04922047
What this trial is testing

Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01)

Who this might be right for
Urinary Bladder NeoplasmsUrologic NeoplasmsUrogenital Neoplasms+3 more
RenJi Hospital 6
Testing effectiveness (Phase 2)Ended earlyNCT03719300
What this trial is testing

Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Anchiano Therapeutics Israel Ltd. 32
Testing effectiveness (Phase 2)Looking for participantsNCT06972615
What this trial is testing

Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy

Who this might be right for
Non Muscle Invasive Bladder Cancer
BLATAM 37
Not applicableUnknownNCT03138824
What this trial is testing

Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC

Who this might be right for
Bladder Urothelial CarcinomaTURBTBladder Neoplasm+1 more
Mansoura University 100
Not applicableNot Yet RecruitingNCT07231809
What this trial is testing

Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients

Who this might be right for
Non Muscle Invasive Bladder CancerBladder CancerCarcinoma in Situ of Bladder+2 more
AC.TA. S.r.l. 50
Post-approval studies (Phase 4)UnknownNCT03221062
What this trial is testing

"En Bloc" Resection of NMIBC: a Prospective， Single Centre，Randomized Study

Who this might be right for
Non-muscle Invasive Bladder Cancer
Tongji Hospital 180
Large-scale testing (Phase 3)Looking for participantsNCT05037279
What this trial is testing

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)

Who this might be right for
Bladder CancerBladder Cancer RecurrentNeoplasm Recurrence+3 more
Verity Pharmaceuticals Inc. 540
Not applicableLooking for participantsNCT07130578
What this trial is testing

The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerLiquid Biopsy
Tianjin Medical University Second Hospital 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04165317
What this trial is testing

Sasanlimab in People With Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Pfizer 1,068
Testing effectiveness (Phase 2)UnknownNCT05957757
What this trial is testing

RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression

Who this might be right for
Non-Muscle Invasive Bladder CancerHER2
RenJi Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT04106115
What this trial is testing

DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr

Who this might be right for
Bladder Cancer
University College, London 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT04386746
What this trial is testing

Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer

Who this might be right for
Urothelial Carcinoma BladderBladder Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT04179162
What this trial is testing

Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment

Who this might be right for
Non-Muscle Invasive Bladder Cancer (NMIBC)
Memorial Sloan Kettering Cancer Center 54
Not applicableLooking for participantsNCT06735287
What this trial is testing

A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerNMIBC
The First Affiliated Hospital with Nanjing Medical University 60
Large-scale testing (Phase 3)Ended earlyNCT01475266
What this trial is testing

Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

Who this might be right for
Bladder Cancer
Nippon Kayaku Co., Ltd. 51
Not applicableActive Not RecruitingNCT07391137
What this trial is testing

CRUCIAL-R Study : Cruciferous Vegetables Dietary Regimen in NMIBC

Who this might be right for
Recurrence Free SurvivalBladder Cancer Recurrence
S. Andrea Hospital 250
Next Page